ATE371680T1 - Polymerkonjugate - Google Patents

Polymerkonjugate

Info

Publication number
ATE371680T1
ATE371680T1 AT03700372T AT03700372T ATE371680T1 AT E371680 T1 ATE371680 T1 AT E371680T1 AT 03700372 T AT03700372 T AT 03700372T AT 03700372 T AT03700372 T AT 03700372T AT E371680 T1 ATE371680 T1 AT E371680T1
Authority
AT
Austria
Prior art keywords
conjugates
moiety
polydispersity
biologically active
active compounds
Prior art date
Application number
AT03700372T
Other languages
English (en)
Inventor
Andrew Lewis
Original Assignee
Biocompatibles Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocompatibles Uk Ltd filed Critical Biocompatibles Uk Ltd
Application granted granted Critical
Publication of ATE371680T1 publication Critical patent/ATE371680T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F246/00—Copolymers in which the nature of only the monomers in minority is defined

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Medicinal Preparation (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
AT03700372T 2002-01-16 2003-01-16 Polymerkonjugate ATE371680T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP02250289 2002-01-16

Publications (1)

Publication Number Publication Date
ATE371680T1 true ATE371680T1 (de) 2007-09-15

Family

ID=27589157

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03700372T ATE371680T1 (de) 2002-01-16 2003-01-16 Polymerkonjugate

Country Status (6)

Country Link
US (2) US8048408B2 (de)
EP (1) EP1465933B1 (de)
AT (1) ATE371680T1 (de)
DE (1) DE60315949T2 (de)
ES (1) ES2291613T3 (de)
WO (1) WO2003062290A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003062290A1 (en) 2002-01-16 2003-07-31 Biocompatibles Uk Limited Polymer conjugates
EP1480619B1 (de) * 2002-03-07 2013-08-07 Biocompatibles UK Limited Wirkstoffträger enthaltend amphiphile blockcopolymere
EP1480680B1 (de) 2002-03-07 2010-11-03 Biocompatibles UK Limited Mit nucleinsäure complexierte block-copolymere
GB0301014D0 (en) * 2003-01-16 2003-02-19 Biocompatibles Ltd Conjugation reactions
EP1590388A2 (de) * 2003-02-05 2005-11-02 Biocompatibles UK Limited Blockcopolymere
GB0314472D0 (en) * 2003-06-20 2003-07-23 Warwick Effect Polymers Ltd Polymer
WO2006003352A1 (en) * 2004-07-06 2006-01-12 Warwick Effect Polymers Limited Living radical polymerization initiator comprising a functional group capable of reacting with polyeptides or the like, comb polymer obtained therewith, polypeptide conjugates and drugs obtained therefrom
WO2005039641A2 (en) * 2003-10-15 2005-05-06 The Regents Of The University Of California Biomacromolecule polymer conjugates
PL1701940T3 (pl) * 2003-12-23 2008-11-28 H Lundbeck As Pochodne 2-(1H-indolilosulfanylo)benzyloaminy jako SSRI
AR052308A1 (es) * 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
US7629473B2 (en) * 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
AR054393A1 (es) * 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
EP3222142A1 (de) 2006-02-28 2017-09-27 Kodiak Sciences Inc. Acryloyloxyethylphosphorylcholin-haltige polymerkonjugate und deren herstellung
ES2444695T3 (es) * 2006-06-23 2014-02-26 Alethia Biotherapeutics Inc. Polinucleótidos y polipéptidos implicados en el cáncer
JP2008060540A (ja) * 2006-08-03 2008-03-13 Seiko Epson Corp 電子デバイスの製造方法、電子デバイスおよび電子機器
WO2008025856A2 (en) 2006-09-01 2008-03-06 Novo Nordisk Health Care Ag Modified glycoproteins
US8575397B2 (en) 2007-02-14 2013-11-05 Biocompatibles Uk Limited Derivatisation of biological molecules
PL2257311T3 (pl) 2008-02-27 2014-09-30 Novo Nordisk As Koniugaty cząsteczek czynnika VIII
CA2740900C (en) 2008-11-03 2019-09-24 Alethia Biotherapeutics Inc. Antibodies that specifically block the biological activity of a tumor antigen
EP2260873B1 (de) 2009-06-08 2019-07-24 Biocompatibles UK Limited Pcylierung von proteinen
WO2011075185A1 (en) 2009-12-18 2011-06-23 Oligasis Targeted drug phosphorylcholine polymer conjugates
EP2536753B1 (de) 2010-02-16 2017-12-20 Novo Nordisk A/S Faktor-VIII-Moleküle mit reduzierter VWF-Bindung
CN102905690B (zh) * 2010-05-21 2016-03-30 西门子医疗保健诊断公司 两性离子试剂
SI3173427T1 (sl) 2011-03-31 2019-08-30 ADC Therapeutics SA, Protitelesa proti antigenu 1, povezanemu z ledvicami, in antigen vezavni fragmenti le-tega
AU2012311484B2 (en) 2011-09-23 2017-04-13 Novo Nordisk A/S Novel glucagon analogues
KR102102239B1 (ko) 2012-01-09 2020-04-21 에이디씨 테라퓨틱스 에스에이 유방암을 치료하기 위한 방법
MX366404B (es) * 2012-11-15 2019-07-08 Apellis Pharmaceuticals Inc Analogos de compstatina de celula reactiva, de acción prolongada u objetivos y composiciones y metodos relacionados.
EP2986313B1 (de) 2013-04-18 2019-06-12 Novo Nordisk A/S Stabile, zeitverzögerte coagonisten des glucagon/glp-1-rezeptors
WO2015035342A2 (en) 2013-09-08 2015-03-12 Oligasis Llc Factor viii zwitterionic polymer conjugates
US9309336B2 (en) 2013-11-27 2016-04-12 King Fahd University Of Petroleum And Minerals Synthesis and antiscalant behavior of a novel polyzwitterionic acid
US10570184B2 (en) 2014-06-04 2020-02-25 Novo Nordisk A/S GLP-1/glucagon receptor co-agonists for medical use
US9840553B2 (en) 2014-06-28 2017-12-12 Kodiak Sciences Inc. Dual PDGF/VEGF antagonists
KR20210013299A (ko) 2014-10-17 2021-02-03 코디악 사이언시스 인코포레이티드 부티릴콜린에스테라제 양성이온성 중합체 컨쥬게이트
KR20250057128A (ko) 2015-12-30 2025-04-28 코디악 사이언시스 인코포레이티드 항체 및 이의 접합체
EP3758737A4 (de) 2018-03-02 2022-10-12 Kodiak Sciences Inc. Il-6-antikörper und fusionskonstrukte und konjugate davon
CA3157509A1 (en) 2019-10-10 2021-04-15 Kodiak Sciences Inc. Methods of treating an eye disorder
JP7849049B2 (ja) * 2020-08-21 2026-04-21 ザ ボード オブ リージェンツ オブ ザ ユニヴァーシティー オブ テキサス システム 機能性のイオン化可能なリン脂質

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5260373A (en) * 1987-03-13 1993-11-09 Repligen Corporation Immobilized immunoglobulin-binding proteins
WO1989005305A1 (en) * 1987-12-09 1989-06-15 3I Research Exploitation Limited Polymers and polymer-peptide conjugates
US5162430A (en) * 1988-11-21 1992-11-10 Collagen Corporation Collagen-polymer conjugates
US5122614A (en) * 1989-04-19 1992-06-16 Enzon, Inc. Active carbonates of polyalkylene oxides for modification of polypeptides
SE466754B (sv) * 1990-09-13 1992-03-30 Berol Nobel Ab Saett att kovalent binda biopolymerer till hydrofila ytor
US5286846A (en) * 1991-06-14 1994-02-15 The Government Of The United States Of America As Represented By The Dept. Of Health And Human Services Amino acid derivative and bromoacetyl modified peptides for the preparation of synthetic peptide polymers, conjugated peptides, and cyclic peptides
WO1993001221A1 (en) 1991-07-05 1993-01-21 Biocompatibles Limited Polymeric surface coatings
JPH05220218A (ja) * 1992-02-13 1993-08-31 Norio Nakabayashi 抗血栓性再生セルロース系膜及びその製造方法
IL104734A0 (en) * 1993-02-15 1993-06-10 Univ Bar Ilan Bioactive conjugates of cellulose with amino compounds
US5919455A (en) * 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
EP0796112A4 (de) * 1994-11-30 1999-12-01 Amur Research Corp Phosphocholin-arzneistoffderivate
US5932462A (en) * 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
US5763548A (en) 1995-03-31 1998-06-09 Carnegie-Mellon University (Co)polymers and a novel polymerization process based on atom (or group) transfer radical polymerization
TW517067B (en) * 1996-05-31 2003-01-11 Hoffmann La Roche Interferon conjugates
DE69707452T3 (de) * 1996-06-12 2015-07-23 Warwick Effect Polymers Ltd. Polymerisation-katalysator und -verfahren
EP0948341A4 (de) * 1996-09-17 2003-05-21 Supergen Inc Derivate von phospholipide medikamenten
US5830432A (en) * 1997-03-31 1998-11-03 Amur Pharmacuticals, Inc. Phospholipid drug derivatives
EP0922446A1 (de) * 1997-12-03 1999-06-16 Applied Research Systems Ars Holding N.V. Lösungsphase Verfahrung zur ortspezifischer Herstellung von GRF-PEG Konjugaten
US6251382B1 (en) * 1998-04-17 2001-06-26 Enzon, Inc. Biodegradable high molecular weight polymeric linkers and their conjugates
US6562330B1 (en) * 1998-11-13 2003-05-13 Biocompatibles Limited Therapeutic use of polymers
DE60027309T2 (de) * 1999-07-02 2006-08-31 Symyx Technologies, Inc., Santa Clara Polymerverzweigungen zur immobilisierung von molekülen auf oberflächen oder substraten, wobei die polymere wasserlösliche oder wasserdispergierbare segmente und sonden aufweisen
AU7025600A (en) * 1999-09-08 2001-04-10 School Of Pharmacy, University Of London, The Uniform molecular weight polymers
GB9924502D0 (en) * 1999-10-15 1999-12-15 Biocompatibles Ltd Polymer blend materials
EP1122258B1 (de) * 2000-02-07 2004-05-12 Biocompatibles UK Limited Silizium enthaltende Verbindungen hergestellt durch Michael Addition als Monomere und Macromere
AU2001274146A1 (en) * 2000-05-29 2001-12-11 Bio Merieux Biocompatible polymer for fixing biological ligands
AU2001292092A1 (en) * 2000-10-06 2002-04-15 Biocompatibles Uk Limited Zwitterionic polymers
US6652886B2 (en) * 2001-02-16 2003-11-25 Expression Genetics Biodegradable cationic copolymers of poly (alkylenimine) and poly (ethylene glycol) for the delivery of bioactive agents
JP4577747B2 (ja) * 2001-06-05 2010-11-10 和光純薬工業株式会社 免疫学的測定法用凝集促進剤
US6939564B2 (en) 2001-06-08 2005-09-06 Labopharm, Inc. Water-soluble stabilized self-assembled polyelectrolytes
US6908963B2 (en) * 2001-10-09 2005-06-21 Nektar Therapeutics Al, Corporation Thioester polymer derivatives and method of modifying the N-terminus of a polypeptide therewith
WO2003062290A1 (en) 2002-01-16 2003-07-31 Biocompatibles Uk Limited Polymer conjugates
EP1480680B1 (de) * 2002-03-07 2010-11-03 Biocompatibles UK Limited Mit nucleinsäure complexierte block-copolymere
EP1480619B1 (de) * 2002-03-07 2013-08-07 Biocompatibles UK Limited Wirkstoffträger enthaltend amphiphile blockcopolymere
GB0301014D0 (en) * 2003-01-16 2003-02-19 Biocompatibles Ltd Conjugation reactions
EP1590388A2 (de) * 2003-02-05 2005-11-02 Biocompatibles UK Limited Blockcopolymere
CA2515612A1 (en) * 2003-02-19 2004-09-02 Pharmacia Corporation Activated polyethylene glycol esters
BRPI0407882B1 (pt) * 2003-02-26 2021-07-27 Nektar Therapeutics Composição compreendendo conjugados de polímero-porção de fator viii e seu método de fabricação
BRPI0412671A (pt) * 2003-08-08 2006-10-03 Fresenius Kabi De Gmbh conjugados de um polìmero e uma proteìna ligados por um grupo de ligação de oxima
WO2005039641A2 (en) * 2003-10-15 2005-05-06 The Regents Of The University Of California Biomacromolecule polymer conjugates
US7179874B2 (en) * 2003-11-21 2007-02-20 Chia Nan University Of Pharmacy And Science Biodegradable cationic polymer
US7365127B2 (en) * 2005-02-04 2008-04-29 Enzon Pharmaceuticals, Inc. Process for the preparation of polymer conjugates
US20070123646A1 (en) * 2005-09-13 2007-05-31 Lele Bhalchandra S Protein-polymer conjugates and synthesis thereof

Also Published As

Publication number Publication date
EP1465933A1 (de) 2004-10-13
US20050123501A1 (en) 2005-06-09
US8431113B2 (en) 2013-04-30
WO2003062290A1 (en) 2003-07-31
ES2291613T3 (es) 2008-03-01
DE60315949T2 (de) 2008-06-12
EP1465933B1 (de) 2007-08-29
DE60315949D1 (de) 2007-10-11
US8048408B2 (en) 2011-11-01
US20120016085A1 (en) 2012-01-19

Similar Documents

Publication Publication Date Title
ATE371680T1 (de) Polymerkonjugate
AU5346896A (en) Heterotelechelic block copolymers and process for producing the same
WO2008076333A3 (en) Polymer-drug conjugates with tether groups for controlled drug delivery
SE9504495D0 (sv) Linjär blockpolymer innefattande urea- och uretangrupper, förfarande för framställning av linjära blockpolymerer samt användning av blockpolymererna som implantat
WO2001030408A3 (en) Adhesive composition over a bioactive polymerization initiator
AU7025600A (en) Uniform molecular weight polymers
AU7522601A (en) Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
WO1999029353A3 (en) Medical devices with improved properties
CA2308721A1 (en) Radio-opaque polymer biomaterials
WO2000027887A3 (en) Cross-linked hyaluronic acids and medical uses thereof
BR9810289A (pt) Processo de preparação de polìmeros em blocos, e, polìmero
TNSN96141A1 (fr) Formulations pharmaceutiques et procede pour leur production
IL112920A0 (en) Bioactive and/or targeted dendrimer conjugates
CA2294036A1 (en) Polyallylamine polymers for treating hypercholesterolemia
TW200407339A (en) Manufacture method of living radical polymers and the polymers
WO2000064486A3 (en) Enzymatically activated polymeric drug conjugates
FR2802208B1 (fr) Procede de synthese de polymeres par polymerisation radicalaire controlee a l'aide de xanthates
WO2005023294A3 (en) Polyacetal drug conjugates as release system
MX9606466A (es) Preparacion de polimeros por polimerizacion en emulsion.
WO2002085377A8 (en) Method for lowering serum glucose
WO2002010223A3 (fr) Procede de synthese de polymeres a blocs par polymerisation radicalaire controlee
WO2003024939A3 (en) Triazine compounds polymers comprising triazine structural units, and processes for the preparation of these polymers
WO2003059382A3 (en) Pharmaceutical compositions comprising polyanionic polymers and amphiphilic block copolymers and methods of use thereof to improve gene expression
TW200726787A (en) Copolymers produced from reacting a glycidyl ester and/or ether with a polyol and the use of the copolymers in coating compositions
DE602004012713D1 (de) Konjugationsreaktionen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties